Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5705_Библиотеки_им_академика_М_И_Перельмана.pdf
188
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
-
6.3.2.1.5
transport (Dolatabadi and de la Guardia, 2011).
condense and transport DNA (Kneuer et al., 2000). It has been demonstrated
rat Achilles tendons Park et al. (2008) linked the mannosylated PEI to the
Nanotechnology in Gene Delivery
189
-
silica nanoparticles through receptor-mediated endocytosis and to lessen
-
Bhakta et al. (2011) developed gadolinium-oxide-doped silica nanoparticles
-
-
tively via endocytosis, BPEI-silica nanotubes delivered plasmid DNA into
3
3
-
Guardia, 2011).
190
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Metallic nanoparticles may be used in imaging and diagnostic procedures.
-
-
applications (Heinemann et al., 2013). Due to their extraordinary physical,
chemical, and biological characteristics, gold glyconanoparticles (GlycoNPs)
-
Nanotechnology in Gene Delivery
191
response. Additionally, siRNAGlycoNPs given via the lungs in vivo are able
6.4 CONCLUSION AND FUTURE PROSPECTS
species, disease type, and tumor environment. Nonetheless, this chapter
employed and their interactions. Moreover, in vitro and preclinical studies
-
into clinical trials using nanoparticle-mediated gene delivery. Although the
extended to people because human physiology is not likely to be adequately
more extracellular barriers to gene delivery to patients than there are to cell
-
192
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
attack, DNA release, and transcription, must also be understood to achieve
-
KEYWORDS
• delivery systems
• nanoparticles
• nucleic acids
• vectors
• nanomedicine
Nanotechnology in Gene Delivery
193
REFERENCES
J. Transl. Med. 2015, 13,
1–16.
Brain Ischemic Insult by Carbon Nanotube-mediated siRNA Silencing. Proc. Natl. Acad.
Sci. 2011, 108, 10952–10957.
Int. J. Nanomed. 2013,
821–834.
Diseases. Int. J. Pharm. 2014, 465, 413–426.
Nanomed.:Nanotechnol.
Biol. Med.
2011, 7, 472–479.
In Vivo
Gene Delivery and Expression in the Brain. Proc. Natl. Acad. Sci. 2005, 102,
11539–11544.
In Situ Gelling Liquid Crystalline System Based
Euro. J. Pharm.
Sci.
2015, 74, 103–117.
Macromol. Rapid
Commun.
2015, 36, 1862–1876.
Adv. Mater. 2005, 17, 404–407.
Exp. Hematol. 2008, 36,
807–815.
ACS Nano. 2015, 9, 1581–1591.
In Vitr o and In Vivo
Enhanced Cancer-cell Killing. Nanoscale 2015, 7, 9083–9091.
194
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Adv. Healthc. Mater. 2015,
4, 223–227.
Curr.
Med. Chem.
2012, 19, 5052–5061.
ACS Nano. 2015, 9,
2290–2302.
TrAC
Tr ends Anal. Chem.
2011, 30, 1538–1548.
Pharmacological Action. Inter. J. Pharm. 2015, 485, 288–294.
Biomaterials 2014, 35,
1725–1734.
Design of Nanostructures for Versatile Therapeutic
Applications,
Biomaterials 2013, 34, 807–816.
Biomacromolecules 2013, 14, 101–109.
Naunyn-
Schmiedeberg’s Arch. Pharmacol.
2022, 395, 769–787.
Apoptosis. Tumor. Biol. 2014, 35, 5013–5019.
Plos One 2013, 8, e58604.
J. Pharm.
Sci. 2013, 102, 227–236.
Micelles. Gene Ther. 2013, 20, 597–606.
Nanotechnology in Gene Delivery
195
Int.
J. Pharm.
2015, 485, 261–269.
Hepatol. 2015, 62, 1285–1297.
Oncogene Suppressor p53 Gene to Breast Cancer MCF-7 Cells. Int. J. Nanomed. 2011,
1045–1055.
Innate Immunity Genes. Gene Ther. 2012, 19, 347–353.
Bioconjug. Chem. 2000, 11, 926–932.
J. Control. Release 2015,
205, 172–180.
Hepatocellular Carcinoma. Mol. Cancer Ther. 2013, 12, 2308–2318.
Macromol. Biosci. 2014, 14, 831–841.
Colloids Surf. B: Biointerfaces 2015, 126, 322–327.
Delivery and MR Imaging. Biomaterials 2011, 32, 3042–3052.
Nat. Commun. 2014, 5,
3545.
Advances in Nanotechnology-
Based Drug Delivery Systems
Delivery. Int. J. Pharm. 2008, 359, 280–287.
Repair. ACS Nano. 2014, 8, 8050–8062.
196
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Delivery. In Advanced Technology for Delivering Therapeutics, IntechOpen, 2017.
Colloids Surf. B: Biointerfaces, 2011, 84,
206–213.
Nano. Lett. 2014, 14, 5257–5263.
Drug Des. Devel. Ther. 2012, 303–310.
Shi, X. Gene Delivery Using Dendrimer-Entrapped Gold Nanoparticles as Non-viral
Vectors. Biomaterials 2012, 33, 3025–3035.
Biomaterials 2010, 31, 5237–5245.
Biomaterials 2011, 32, 5402–5410.
Int. J. Pharm. 2011,
416, 419–425.
Applications. Nano. Res. 2008, 1, 99–115.
ActaBiomater. 2015, 17,
115–124.
Trends Biotechnol. 2017, 35,
434–451.
Sci.
Rep.
2014, 4, 7471.
Advances in Pharmaceutical T echnology for Drug Delivery Systems (PTDDS), Volume 2: Recent Progress
in Biomedical Applications. Sougata Jana (Ed.)
© 2025 Apple Academic Press, Inc. Co-published with CRC Press (Taylor & Francis)
3D Printed Devices as Drug Delivery
Systems
ITALO RODRIGO CALORI, ANA PAULA PEREIRA GUIMARÃES, and
ANTONIO CLAUDIO TEDESCO
Department of Chemistry, Center of Nanotechnology and Tissue
CHAPTER 7
ABSTRACT
-
humans, the orodispersible tablet Spritam
®
-
systems, the main chemical ingredients used as additives in pharmacology,
drug release.